Aprameya Engineering Quarterly Results for Trading Insights
APRAMEYA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹16 Cr
QMarch 2025
Aprameya Engineering Quarterly Results Key Highlights
- Revenue of ₹136 Cr in March 2025 (+0.0% vs March 2025, +106.1% vs March 2024)
- Net Profit of ₹16 Cr in March 2025 (+0.0% vs March 2025, +300.0% vs March 2024)
- EBITDA of ₹25 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 18.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹9.27 in March 2025 (+0.0% vs March 2025)
Aprameya Engineering Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 136 | 66 | 78 | 35 | - | - |
| Net Profit (₹ Cr) | 0 | 16 | 4 | 5 | 8 | - | - |
| EBITDA (₹ Cr) | 0 | 25 | 7 | 10 | 10 | - | - |
| EPS (₹) | 0.00 | 9.27 | 2.49 | 3.84 | 10.65 | - | - |
| Operating Margin (%) | 0.0% | 18.0% | 10.0% | 12.0% | 29.0% | - | - |
Aprameya Engineering Share Price Trend Around Quarterly Results
Visualize Aprameya Engineering's 1-year price movement across quarterly results — ideal for logging trades in Aprameya Engineering share price
chart using Tickjournal. All values in ₹.
Related Pages for Aprameya Engineering
Additional stock information and data for APRAMEYA
Revenue Trend (₹ Cr)
March 2023
78
March 2024
66
March 2025
136
2026
0
Net Profit Trend (₹ Cr)
March 2023
5
March 2024
4
March 2025
16
2026
0
Operating Margin Trend (%)
March 2023
12.0%
March 2024
10.0%
March 2025
18.0%
2026
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Aprameya Engineering quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹409,758.43 Cr | 1711.1 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.6 |
|
Divis Laboratories
Sept 2025 |
₹163,940.12 Cr | 6386.5 | 2,860 | 689 | +7.1% | - | 24.1% | 245.9 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹138,072.20 Cr | 4056.7 | 3,219 | 591 | +11.3% | - | 18.4% | 231.3 |
|
Cipla
Sept 2025 |
₹109,041.12 Cr | 1349.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1270.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores